These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21870060)

  • 1. Effects of dietary factors on lipoprotein-associated phospholipase A(2) (Lp-PLA (2)).
    Wong CK; White HD
    Curr Atheroscler Rep; 2011 Dec; 13(6):461-6. PubMed ID: 21870060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary, lifestyle, and clinical predictors of lipoprotein-associated phospholipase A2 activity in individuals without coronary artery disease.
    Hatoum IJ; Nelson JJ; Cook NR; Hu FB; Rimm EB
    Am J Clin Nutr; 2010 Mar; 91(3):786-93. PubMed ID: 20107195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2.
    Rosenson RS; Stafforini DM
    J Lipid Res; 2012 Sep; 53(9):1767-82. PubMed ID: 22665167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrospray ionization mass spectrometry identifies substrates and products of lipoprotein-associated phospholipase A2 in oxidized human low density lipoprotein.
    Davis B; Koster G; Douet LJ; Scigelova M; Woffendin G; Ward JM; Smith A; Humphries J; Burnand KG; Macphee CH; Postle AD
    J Biol Chem; 2008 Mar; 283(10):6428-37. PubMed ID: 18165686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of atherosclerosis in apolipoprotein E-deficient mice by inhibition of lipoprotein-associated phospholipase A2.
    Zhang H; Zhang JY; Sun TW; Shen DL; He F; Dang YH; Li L
    Clin Invest Med; 2013 Feb; 36(1):E32-41. PubMed ID: 23374598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein-associated phospholipase A₂ activity predicts progression of subclinical coronary atherosclerosis.
    Kinney GL; Snell-Bergeon JK; Maahs DM; Eckel RH; Ehrlich J; Rewers M; Hokanson JE
    Diabetes Technol Ther; 2011 Mar; 13(3):381-7. PubMed ID: 21291330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin reduces expression and activity of lipoprotein-associated phospholipase A(2) in the aorta of hypercholesterolaemic atherosclerotic rabbits.
    Qiao Z; Ren J; Chen H
    J Int Med Res; 2009; 37(4):1029-37. PubMed ID: 19761685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining rosuvastatin with sartans of different peroxisome proliferator-activated receptor-γ activating capacity is not associated with different changes in low-density lipoprotein subfractions and plasma lipoprotein-associated phospholipase A₂.
    Rizos CV; Liberopoulos EN; Tellis CC; Florentin M; Elisaf MS; Tselepis AD
    Metab Syndr Relat Disord; 2011 Jun; 9(3):217-23. PubMed ID: 21352079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of lipoprotein-associated phospholipase A₂ mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: an analysis from the JUPITER trial.
    Ridker PM; MacFadyen JG; Wolfert RL; Koenig W
    Clin Chem; 2012 May; 58(5):877-86. PubMed ID: 22419750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of lipoprotein-associated phospholipase A2 mass and activity with coronary and aortic atherosclerosis: findings from the Dallas Heart Study.
    Brilakis ES; Khera A; Saeed B; Banerjee S; McGuire DK; Murphy SA; de Lemos JA
    Clin Chem; 2008 Dec; 54(12):1975-81. PubMed ID: 18832472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translational studies of lipoprotein-associated phospholipase A₂ in inflammation and atherosclerosis.
    Ferguson JF; Hinkle CC; Mehta NN; Bagheri R; Derohannessian SL; Shah R; Mucksavage MI; Bradfield JP; Hakonarson H; Wang X; Master SR; Rader DJ; Li M; Reilly MP
    J Am Coll Cardiol; 2012 Feb; 59(8):764-72. PubMed ID: 22340269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-by-diet effects on co-variation in Lp-PLA2 activity and LDL-cholesterol concentration in baboons fed an atherogenic diet.
    Vinson A; Mahaney MC; Diego VP; Cox LA; Rogers J; VandeBerg JL; Rainwater DL
    J Lipid Res; 2008 Jun; 49(6):1295-302. PubMed ID: 18334716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of lipoprotein-associated phospholipase A2 and oxidized low density lipoprotein in carotid atherosclerosis.
    Vickers KC; Maguire CT; Wolfert R; Burns AR; Reardon M; Geis R; Holvoet P; Morrisett JD
    J Lipid Res; 2009 Sep; 50(9):1735-43. PubMed ID: 19359705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and purification of lipoprotein-associated phospholipase A(2), a key enzyme involved in atherosclerosis.
    Zhang FJ; Cai MJ; Shen JK; Wang YP
    Acta Pharmacol Sin; 2006 Jun; 27(6):679-84. PubMed ID: 16723085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
    Mohler ER; Ballantyne CM; Davidson MH; Hanefeld M; Ruilope LM; Johnson JL; Zalewski A;
    J Am Coll Cardiol; 2008 Apr; 51(17):1632-41. PubMed ID: 18436114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke.
    Caslake MJ; Packard CJ
    Nat Clin Pract Cardiovasc Med; 2005 Oct; 2(10):529-35. PubMed ID: 16186851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 fatty acids and lipoprotein associated phospholipase A(2) in healthy older adult males and females.
    Nelson TL; Hokanson JE; Hickey MS
    Eur J Nutr; 2011 Apr; 50(3):185-93. PubMed ID: 20706728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein-associated phospholipase A2 activity and risk of recurrent stroke.
    Elkind MS; Tai W; Coates K; Paik MC; Sacco RL
    Cerebrovasc Dis; 2009; 27(1):42-50. PubMed ID: 19018137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lp-PLA2: A new target for statin therapy.
    Braun LT; Davidson MH
    Curr Atheroscler Rep; 2010 Jan; 12(1):29-33. PubMed ID: 20425268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.
    Chu AY; Guilianini F; Grallert H; Dupuis J; Ballantyne CM; Barratt BJ; Nyberg F; Chasman DI; Ridker PM
    Circ Cardiovasc Genet; 2012 Dec; 5(6):676-85. PubMed ID: 23118302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.